Table 3 Ocular complications at presentation and during follow-up.
Complications | At presentation n (%) | During follow-up n (%) | Duration from presentation to complication onset in months (median [IQR]) |
|---|---|---|---|
Cataract | 15 (26.3) | 9 (15.8) | 12.68 (7.68, 13.01) |
Elevated IOP requiring management | 6 (10.5) | 19 (33.3) | 4.51 (1.28, 12.09) |
Posterior synechia | 20 (35.1) | 3 (5.3) | 11.47 (11.47, 11.47) |
Band keratopathy | 18 (31.6) | 8 (14) | 13.75 (9.72, 27.81) |
Retinal detachment | |||
Rhegmatogenous (RRD) | 3 (5.3) | 4 (7) | 6.85 (5.49, 9.41) |
Exudative (ERD) | 4 (7) | 0 | – |
Tractional (TRD) | 4 (7) | 9 (15.8) | 11.73 (8.54, 31.80) |
Optic disc hyperemia/edema | 14 (24.6) | 1 (1.8) | 2.07 (2.07, 2.07) |
Macular edema | 14 (24.6) | 4 (7) | 14.57 (9.43, 41.33) |
Macular scar/atrophy | 2 (3.5) | 1 (1.8) | 14.55 (14.55, 14.55) |
Epiretinal membrane | 3 (5.3) | 5 (8.8) | 8.08 (4.53, 12.16) |
Hypotony | 4 (7) | 6 (10.5) | 7.80 (3.68, 48.36) |
Optic atrophy | 2 (3.5) | 8 (14) | 15.26 (5.09, 33.18) |
Optic disc neovascularization | 3 (5.3) | 2 (3.5) | 2.05 (0.46, 3.65) |
Retinal neovascularization | 3 (5.3) | 2 (3.5) | 3.94 (0.98, 6.90) |
Iris neovascularization | 1 (1.8) | 5 (8.8) | 35.91 (1.77, 59.92) |
Vitreous hemorrhage | 1 (1.8) | 6 (10.5) | 9.66 (1.15, 42.15) |
Atrophic bulbi | 1 (1.8) | 7 (12.3) | 16.98 (4.51, 40.93) |
Central retinal vein occlusion | 1 (1.8) | 0 | – |
